إعلان
إعلان

SER

SER logo

Serina Therapeutics, Inc.

2.50
USD
برعاية
-0.12
-4.58%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

2.43

-0.07
-2.80%

تقارير أرباح SER

النسبة الإيجابية المفاجئة

SER تفوق 2 من 3 آخر التقديرات.

67%

التقرير التالي

بيانات التقرير القادم
٢٣ مارس ٢٠٢٦
Estimate for Q4 26 (Revenue/ EPS)
--
/
-$0.44
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
-13.73%
التغير الضمني من Q4 25 (Revenue/ EPS)
--
/
--

Serina Therapeutics, Inc. earnings per share and revenue

On ١٣ نوفمبر ٢٠٢٥, SER reported earnings of -0.51 USD per share (EPS) for Q3 25, beating the estimate of -0.53 USD, resulting in a 4.73% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.49% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 3 المحللين forecast an EPS of -0.44 USD, with revenue projected to reach -- USD, implying an نقصان of -13.73% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Serina Therapeutics, Inc. reported EPS of -$0.51, beating estimates by 4.73%, and revenue of $0.00, 0% as expectations.
The stock price moved down -2.49%, changed from $4.02 before the earnings release to $3.92 the day after.
The next earning report is scheduled for ٢٣ مارس ٢٠٢٦.
Based on 3 المحللين, Serina Therapeutics, Inc. is expected to report EPS of -$0.44 and revenue of -- for Q4 2026.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان